Amsterdam-based BMEYE Completes €6M Series B Financing Round

BMEYE B.V., a provider cardiovascular monitoring systems, completed its 6m Series B financing round led by new investors Earlybird with participation from 360 Capital Partners, Life Sciences Partners and Techfund.
The funds will support the accelerated growth program of the company based on further product introductions and development of the sales channel.
Commenting on the round, Rob de Ree, BMEYE’s Chief Executive Officer, said: “We are pleased to have completed this financing round, especially given today’s challenging economic climate”.
Amsterdam-based BMEYE, which was founded in 2005, closed its Series A round with LSP as the lead investor in 2006.

Join the discussion